Ascend Wellness Holdings, Inc. (AAWH) Posts Fourth Quarter Loss, Surpasses Revenue Projections

Ascend Wellness Holdings, Inc. Reports Quarterly Results

Ascend Wellness Holdings, Inc. (AAWH) announced a net loss of $0.16 per share for the latest quarter, which was wider than the Zacks Consensus Estimate of a $0.12 loss. In comparison, the company reported a loss of $0.08 per share during the same period last year. These results exclude one-time items.

This quarter's performance resulted in a negative earnings surprise of 39.13%. In the previous quarter, the company was projected to lose $0.10 per share but actually reported a loss of $0.13, missing expectations by 30%.

For the past four quarters, Ascend Wellness Holdings has not exceeded consensus earnings per share forecasts.

Operating within the Zacks Medical Services sector, Ascend Wellness Holdings generated $120.55 million in revenue for the quarter ending December 2025, slightly surpassing the consensus estimate by 0.46%. However, this figure is down from $136.01 million in the prior year. Over the last year, the company has only beaten revenue expectations once.

The immediate direction of the stock price will likely be influenced by management’s insights shared during the earnings call, as well as future earnings projections.

Since the start of the year, shares of Ascend Wellness Holdings have declined approximately 30.4%, compared to a 1% drop in the S&P 500.

Looking Ahead for Ascend Wellness Holdings, Inc.

Despite underperforming the broader market this year, investors are now questioning what lies ahead for Ascend Wellness Holdings’ stock.

One key factor to consider is the company’s earnings outlook, which includes both current consensus estimates for upcoming quarters and recent changes in those estimates.

Research consistently demonstrates a strong link between short-term stock price movements and trends in earnings estimate revisions. Investors can monitor these changes themselves or use established tools like the Zacks Rank, which has a proven record of leveraging earnings estimate trends.

Prior to this earnings announcement, estimate revisions for Ascend Wellness Holdings were mixed. Although these may shift following the latest results, the stock currently holds a Zacks Rank #3 (Hold), indicating it is expected to perform similarly to the overall market in the near term. You can view the full list of today’s Zacks #1 Rank (Strong Buy) stocks here.

It remains to be seen how analyst estimates for future quarters and the current fiscal year will evolve. Presently, the consensus forecast is for an EPS of -$0.12 on $124.1 million in revenue for the next quarter, and -$0.27 on $523.27 million in revenue for the full year.

Investors should also consider the broader industry outlook, as it can significantly affect stock performance. The Medical Services industry currently ranks in the bottom 43% among more than 250 Zacks industries. Historically, the top half of Zacks-ranked industries outperforms the lower half by more than two to one.

Industry Comparison: Synergy CHC Corp. (SNYR)

Another company in the same sector, Synergy CHC Corp. (SNYR), has not yet released its results for the quarter ending December 2025.

• Synergy CHC Corp. is anticipated to report earnings of $0.01 per share, unchanged from the previous year’s quarter.
• The consensus EPS estimate for the quarter has remained stable over the past month.
• Revenue is projected at $11.05 million, representing a 7.3% increase year-over-year.

Is Ascend Wellness Holdings, Inc. (AAWH) a Good Investment?

Thinking about investing in Ascend Wellness Holdings, Inc. (AAWH)? For insights on top stock picks for the next month, explore Zacks Investment Research’s free report on the 7 best stocks to buy now.

Since 1978, Zacks Investment Research has provided independent research and tools for investors. Over the past 25+ years, the Zacks Rank stock-rating system has delivered an average annual return of +24.08%, more than doubling the S&P 500 (from January 1, 1988 through May 6, 2024).

Want the most up-to-date stock recommendations from Zacks? Download the 7 Best Stocks for the Next 30 Days. Click here for your free report.